ElmediX
Company

Last deal

$5.4M
Local Amount - EUR 5M

Amount

Series A

Stage

14.06.2024

Date

2

all rounds

$9.9M

Total amount

General

About Company
ElmediX develops semi-automated hyperthermal therapy system to improve pancreatic cancer treatment.

Industry

Sector :

Subsector :

founded date

01.01.2015

Number of employees

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

Developer of a thermal therapy designed to offer an improved treatment with reduced side effects. The company's therapy is a treatment that strengthens the immune system, kills cancer cells, increases the absorption of chemotherapy drugs, and makes cancer cells more sensitive to radiation, enabling healthcare industry to develop products that have a minimal impact on the environment in terms of design, raw materials, production, packaging, recycling, and waste disposal.
Contacts

Phone number

Social url